AngioWaveNet vs AI-ECG Tracker

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Angiowave Imaging
VS
by Carewell Health

AI Verdict

Both AngioWaveNet and AI-ECG Tracker are FDA-cleared AI tools operating within the cardiology domain. AngioWaveNet is designed to enhance fluoroscopic angiograms for improved vessel visualization during cardiac catheterization procedures. Conversely, AI-ECG Tracker focuses on providing rapid, AI-powered auto-analysis and diagnosis of cardiac abnormalities from 12-lead ECG data.

Choose AngioWaveNet if…

Choose AngioWaveNet if your primary need is to enhance the clarity and visibility of blood vessels and anatomical structures during fluoroscopic angiograms in a cardiac catheterization lab. This tool is ideal for improving real-time procedural guidance and diagnostic accuracy during interventional cardiology or vascular surgery procedures, seamlessly integrating with your existing vendor-agnostic angiography systems.

View AngioWaveNet →

Choose AI-ECG Tracker if…

Choose AI-ECG Tracker if your priority is rapid, highly accurate, and automated diagnosis of cardiac abnormalities from 12-lead ECG data. This solution is best suited for cardiology and emergency medicine settings requiring quick identification of conditions like arrhythmias, myocardial ischemia, or infarction, providing comprehensive diagnostic support in approximately three seconds.

View AI-ECG Tracker →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AngioWaveNet AI-ECG Tracker
Pricing Pricing options include annual software licensing or subscription-based access, tailored to cath lab volume and hospital needs. custom packages are available. Unknown
Deployment Cloud-based or on-premise/servers Mobile app, intended for use by qualified healthcare professionals in hospitals and other healthcare facilities.
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AngioWaveNet

AngioWaveNet emphasizes seamless integration with existing, vendor-agnostic cath lab workflows and requires minimal training, indicating high usability in a complex clinical environment. Its design focuses on non-disruptive adoption and ease of use for clinicians and staff. While AI-ECG Tracker offers a dedicated workstation and rapid diagnosis, AngioWaveNet's focus on integration and low learning curve provides a stronger advantage in usability.

Clinical Value

AI-ECG Tracker

Both tools offer significant clinical value and are FDA-cleared. AI-ECG Tracker provides highly accurate (over 95%) and comprehensive diagnostic support for 16 cardiac classifications and 104 ECG diagnostic classifications, offering specific quantitative metrics of its clinical utility. While AngioWaveNet improves vessel visualization, AI-ECG Tracker's direct diagnostic capabilities across a broad range of conditions present a more extensive and quantifiable clinical impact.

Pricing & Value

AngioWaveNet

AngioWaveNet offers transparent and flexible pricing models, including annual software licensing or subscription-based access tailored to cath lab volume and hospital needs. This transparency allows potential customers to better assess the value proposition. In contrast, AI-ECG Tracker's pricing information is not publicly available, making it difficult for prospective buyers to evaluate its cost-effectiveness.

Enterprise Readiness

AngioWaveNet

Both tools are FDA-cleared and offer flexible deployment options. However, AngioWaveNet explicitly states HIPAA compliance and highlights vendor-agnostic compatibility with any fluoroscopic angiography system, functioning as a DICOM endpoint, which are crucial for seamless integration into diverse enterprise IT environments. AI-ECG Tracker's HIPAA compliance is only stated as 'likely,' giving AngioWaveNet a clearer advantage in explicit readiness for large-scale healthcare deployments.

Innovation

AngioWaveNet

AngioWaveNet introduces 'deep-learningu2013based spatiotemporal enhancement processing (STEPu2122)' to fluoroscopic angiography, a 'mature technology' that has seen little innovation in the past 20 years. This represents a novel approach to improving real-time procedural visualization. While AI-ECG Tracker's high accuracy in auto-diagnosis is impressive, AngioWaveNet's specific, advanced image processing technique in a stagnant field demonstrates a more distinct innovative leap.

Support & Docs

AngioWaveNet

AngioWave Imaging explicitly details comprehensive onboarding support for AngioWaveNet, including installation assistance, staff training, and access to ongoing updates and clinical resources, along with a claim of minimal training required. While AI-ECG Tracker's parent company offers general service commitments and warranties, AngioWaveNet provides more specific and product-centric support information, indicating a clearer path for user assistance and adoption.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AngioWaveNet AI-ECG Tracker
Name AngioWaveNet AI-ECG Tracker
Company Angiowave Imaging Shenzhen Carewell Electronics Co. (a subsidiary of Lepu Medical)
Primary Function Enhances fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories. AI software for ECG auto-analysis and diagnosis of cardiac abnormalities.
Categories Cardiology AI, Radiology & Imaging AI Cardiology AI
Specialties Cardiology, Interventional Radiology, Vascular Surgery Cardiology, Emergency Medicine
Key AI Functionality AI-powered Spatiotemporal Enhancement Processing (STEPu2122) for improved vessel visualization in fluoroscopic angiograms. AI-powered ECG auto-analysis and diagnosis with high accuracy for common cardiac abnormalities, supporting 12-lead ECG data.

Videos

Demos, reviews, and walkthroughs featuring AngioWaveNet and AI-ECG Tracker.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AngioWaveNet is FDA-cleared AI software that enhances fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories. AI-ECG Tracker provides AI-powered auto-analysis and diagnosis of 12-lead ECG data for various cardiac abnormalities, including arrhythmias, ventricular hypertrophy, myocardial ischemia, and myocardial infarction.
AngioWaveNet integrates with existing Cath lab workflows and is compatible with any fluoroscopic angiography system as a DICOM endpoint. AI-ECG Tracker utilizes an AI-ECG Workstation and Diagnostic Client, with an optional cloud service (Lepu Nebula Cloud) for remote diagnostic services.
AngioWaveNet focuses on enhancing the visibility of blood vessels, vascular structures, and anatomical features in fluoroscopic angiographic images. AI-ECG Tracker provides high-accuracy diagnosis for common cardiac abnormalities, supporting 16 cardiac classifications and 104 ECG diagnostic classifications.
AI Tool Finder
AI-powered search. Results may not be comprehensive.